Navigation Links
David Smith Named Vice President of Operations for HealthTell
Date:1/10/2013

Chandler, Arizona (PRWEB) January 10, 2013

Dr. Smith will oversee all of HealthTell’s diagnostic chip manufacturing and technical infrastructure development.

“Dr. Smith’s diverse background in biotechnology management and proven execution capabilities give him a unique combination of skills necessary to lead our operations”, said Bill Colston, CEO of HealthTell. “He provides a critical asset in helping us commercialize and provide the enormous economies of scale necessary to meet our business strategy.”

Prior to his new position, Dr. Smith served in senior leadership positions across multiple biotechnology companies, including Affymetrix, 454 Life Sciences, and Codon Devices. A common theme across these companies was Dr. Smith’s ability to transition complex technology from early feasibility to mass production within very short time frames.

Dr. Smith received his BS degree in chemistry from North Central College and his Ph.D. in chemistry from University of Arizona.

About HealthTell

HealthTell, Inc. is an early stage life sciences company focused on providing a service for early screening of cancer and other chronic diseases. HealthTell has developed a unique technology for measuring the “temperature” of an individual’s immune system from a single drop of blood. Similar to how a fever can be used to register the presence of an infection, this assay measures the immune response created by the amplification of billions of antibody molecules in response to specific diseases. HealthTell’s test provides the most specific, early possible detection of disease.

More information about HealthTell is available at http://www.healthtell.com.

Read the full story at http://www.prweb.com/releases/2013/1/prweb10308612.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related biology technology :

1. DuPont Congratulates David Hula for Highest Overall Yield with Pioneer® hybrid – P2088YHR in 2012 NCGA Corn Yield Contest
2. David Lichtenstein: Biotechnology is Rich Area for Investment
3. Renowned Operations and Supply Chain Expert Dr. David Simchi-Levi Joins OPS Rules
4. Maine Center for Creativity Selects Glenn Close and David Shaw to Receive Inaugural Maine Creative Industry Award
5. China Biologic Products Names Chairman David Gao to Additional Post of CEO
6. Dr. David L. Blecker MD, MPH, F.A.C.P. Joins Inergetics Advisory Board to Co-Develop and Market Products to Penetrate Nephrology Market
7. PAREXEL Appoints Former Senior FDA Official David Elder to Global Team of Strategic Compliance Experts
8. Smith & Nephew Announces Agreement To Acquire Assets Of Healthpoint Biotherapeutics
9. Law Office of Brodsky & Smith, LLC Announces Investigation of Complete Genomics, Inc.
10. Upsher-Smith Currently Recruiting People With Epilepsy To Evaluate Investigational Rescue Treatment For Seizure Clusters
11. Upsher-Smith Launches B-Nexa® Prescription Prenatal Vitamin With B Vitamins and Ginger for Nausea and Vomiting of Pregnancy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 23, 2017  GlobeImmune, Inc. today announced it has ... of 12,835,490 shares of its common stock to NantCell, ... connection with the sale of its common stock, NantCell ... issue to GlobeImmune 200,000 shares, an estimated $2.0 million ... "We are pleased to enter into this strategic agreement ...
(Date:3/23/2017)... March 23, 2017 NetworkNewsWire Editorial Coverage  ... Cancer ... significant strain on health care systems, in terms of costs ... so too does the development of innovative and efficient therapies ... Among the many types of cancer treatments, a growing number ...
(Date:3/23/2017)... ... March 23, 2017 , ... Advanced Polymer Monitoring Technologies ... Dr. Sigmund “Sig” Floyd as Vice President ? Global Business Development. Dr. Floyd ... , “Dr. Floyd’s career has spanned 30 years in the chemicals and equipment ...
(Date:3/22/2017)... 2017  UBM and the Massachusetts Medical Device ... partnership and the third annual Massachusetts Medtech Week. Massachusetts ... st Annual MassMEDIC Conference held in conjunction ... 2017. MassMEDIC will feature a ... and CEO, Scott Whitaker , at its ...
Breaking Biology Technology:
(Date:2/27/2017)... --  Strategic Cyber Ventures , the industry,s first cybersecurity ... million investment in  Polarity , the first commercial human ... based and is led by cybersecurity veterans Tom ... Gula , also a longtime cybersecurity veteran and founder ... A round of funding. This new funding will be ...
(Date:2/21/2017)... Der weltweite Biobanking-Sektor wird bis ... Gespräch mit mehr als 50 Vertretern aus verschiedenen Branchen wurde ... um diese Prognose zu realisieren. ... Zu den Schwierigkeiten ... Mittel für die Biobank, die Implementierung Zeit sparender Technologien, ...
(Date:2/10/2017)... Research and Markets has announced the addition of ... Commercial Aspects" to their offering. ... Biomarkers play an important ... selection of treatment as well for monitoring the results. There ... modern medicine. Biochip/microarray technologies and next generation sequencing are also ...
Breaking Biology News(10 mins):